Aurinia Pharma (AUP) Receives a Buy from H.C. Wainwright

According to The Fly, aurinia Pharma (AUP – Research Report), the Healthcare company, has received a rating update from a Wall Street analyst today. Analyst Ed Arce from H.C. Wainwright rated Aurinia More »

H.C. Wainwright Upgrades Valeant Pharm International (VRX) to Buy

According to The Fly, in a new note to investors today, an analyst has provided a rating update for Valeant Pharm International (VRX – Research Report). Ram Selvaraju, an analyst with H.C. More »